TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive FDA, NCI united in pursuit of 2015 goal, Andrew von Eschenbach tells cancer center directors; says his appointment was necessary to “maintain the momentum of the FDA.” October 21, 2005
TCL Archive Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure August 12, 1988
